Sobieraj D M (Diana M Sobieraj, D M Sobieraj)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Chronic Obstructive Pulmonary Disease

Atrial Fibrillation

Direct Oral Anticoagulants

Top Venues

The Annals of pharmacotherapy

Addiction science & clinical practice

Pharmacy (Basel, Switzerland)

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Adams K K, Miech E J, Sobieraj D M
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis. Addiction science & clinical practice 17 (1) (2022)
William L Baker, Sobieraj D M, Robert J DiDomenico
Influence of digoxin on mortality in patients with atrial fibrillation: Overview of systematic reviews. Pharmacotherapy 41 (4) (2021)
Ashley E Johnson, Jillian Barrack, Jill M Fitzgerald, Sobieraj D M, Lisa M Holle
Integration of a Virtual Dispensing Simulator "MyDispense" in an Experiential Education Program to Prepare Students for Community Introductory Pharmacy Practice Experience. Pharmacy (Basel, Switzerland) 9 (1) (2021)
Stefanie C Nigro, Sobieraj D M
Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease. The Annals of pharmacotherapy (2021)
Kathleen K Adams, M Machnicz, Sobieraj D M
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review. Addiction science & clinical practice 16 (1) (2021)
Douglas Buckheit, Amanda Lefemine, Sobieraj D M, Laura Hobbs
Venous Thromboembolism Prophylaxis in Underweight Hospitalized Patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 27 (2021)
Kathleen K Adams, William L Baker, Sobieraj D M
Myth Busters: Dietary Supplements and COVID-19. The Annals of pharmacotherapy 54 (8) (2020)